Business transformation services company Genpact (NYSE:G) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. Genpact beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $1.25 billion, up 8.9% year on year. It was a strong quarter for the company, with a solid beat of analysts’ constant currency revenue estimates and an impressive beat of analysts’ full-year EPS guidance estimates. Is Genpact a buy or sell going into earnings? Read our full analysis here, it’s free. This quarter, analysts are expecting Genpact’s revenue to grow 7% year on year to $1.21 billion, improving from the 3.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.79 per share.Genpact Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Genpact has missed Wall Street’s revenue estimates three times over the last two years. Looking at Genpact’s peers in the business process outsourcing & consulting segment, some have already reported their Q1 results, giving us a hint as to what we can expect. CRA delivered year-on-year revenue growth of 5.9%, beating analysts’ expectations by 3%, and Exponent reported flat revenue, topping estimates by 2.1%. CRA traded up 3.4% following the results while Exponent was down 1.3%. Read our full analysis of CRA’s results here and Exponent’s results here. There has been positive sentiment among investors in the business process outsourcing & consulting segment, with share prices up 11.2% on average over the last month. Genpact is up 5.9% during the same time and is heading into earnings with an average analyst price target of $56.13 (compared to the current share price of $49.57). Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. View Comments
Genpact (G) Reports Q1: Everything You Need To Know Ahead Of Earnings
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...